A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Recruiting

Phase 3

Baloxavir MarboxilA Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Sponsor:

Hoffmann-La Roche

Code:

NCT06094010

Conditions

Influenza

Eligibility Criteria

Sex: All

Age: 3 - 11

Healthy Volunteers: Not accepted

Interventions

Baloxavir Marboxil

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-23. This information was provided to ClinicalTrials.gov by Hoffmann-La Roche on 2025-08-06.